Table of Contents USA Diabetic Gastroparesis Treatment Market Report 2012-2023 1 Diabetic Gastroparesis Treatment Overview 1.1 Product Overview and Scope of Diabetic Gastroparesis Treatment 1.2 Classification of Diabetic Gastroparesis Treatment by Product Category 1.2.1 USA Diabetic Gastroparesis Treatment Sales (K Units) Comparison by Types (2012-2023) 1.2.2 USA Diabetic Gastroparesis Treatment Sales (K Units) Market Share by Types in 2017 1.2.3 Gastroprokinetic Agents 1.2.4 Antiemetic Agents 1.2.5 Botulinum Toxin 1.3 USA Diabetic Gastroparesis Treatment Market by Application/End Users 1.3.1 USA Diabetic Gastroparesis Treatment (K Units) and Market Share Comparison by Applications (2012-2023) 1.3.2 Compensated Gastroparesis 1.3.3 Gastric Failure 1.3.4 Others 1.4 USA Diabetic Gastroparesis Treatment Market by Region 1.4.1 USA Diabetic Gastroparesis Treatment Revenue (Million USD) Comparison by Regions (2012-2023) 1.4.2 Northeast Status and Prospect (2012-2023) 1.4.3 Midwest Status and Prospect (2012-2023) 1.4.4 South Status and Prospect (2012-2023) 1.4.5 West Status and Prospect (2012-2023) 1.5 USA Sales and Revenue ofSales and Revenue of Diabetic Gastroparesis Treatment (2012-2023) 1.5.1 USA Diabetic Gastroparesis Treatment Sales (K Units) and Growth Rate (2012-2023) 1.5.2 USA Diabetic Gastroparesis Treatment Revenue (Million USD) and Growth Rate (2012-2023) 2 Industrial Chain Analysis 2.1 Industry Chain Structure of Diabetic Gastroparesis Treatment 2.2 Raw Material Analysis of Diabetic Gastroparesis Treatment 2.1.1 Raw Material A Market Analysis 2.1.2 Raw Material B Market Analysis 2.1.3 Raw Material C Market Analysis 2.3 Labor Cost Analysis of Diabetic Gastroparesis Treatment 2.4 Other Costs Analysis of Diabetic Gastroparesis Treatment 2.5 Manufacturing Cost Structure Analysis of Diabetic Gastroparesis Treatment 2.6 Manufacturing Process Analysis of Diabetic Gastroparesis Treatment 2.7 Raw Materials Sources of Diabetic Gastroparesis Treatment Major Manufacturers in 2018 2.8 Downstream Buyers 3 USA Diabetic Gastroparesis Treatment Players/Suppliers Profiles and Sales Data 3.1 Janssen Global Services, LLC 3.1.1 Company Basic Information, Manufacturing Base and Competitors 3.1.2 Diabetic Gastroparesis Treatment Product Category, Application and Specification 3.1.2.1 Product A 3.1.2.2 Product B 3.1.3 Janssen Global Services, LLC Diabetic Gastroparesis Treatment Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.1.4 Janssen Global Services, LLC Different Types of Diabetic Gastroparesis Treatment Sales (K Units), Revenue (Million USD) and Price (USD/Unit) and (2012-2017) 3.1.5 Janssen Global Services, LLC Diabetic Gastroparesis Treatment Volume in Different Applications and Its Application Share 3.2 Evoke Pharma 3.2.1 Company Basic Information, Manufacturing Base and Competitors 3.2.2 Diabetic Gastroparesis Treatment Product Category, Application and Specification 3.2.2.1 Product A 3.2.2.2 Product B 3.2.3 Evoke Pharma Diabetic Gastroparesis Treatment Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.2.4 Evoke Pharma Different Types of Diabetic Gastroparesis Treatment Sales (K Units), Revenue (Million USD) and Price (USD/Unit) and (2012-2017) 3.2.5 Evoke Pharma Diabetic Gastroparesis Treatment Volume in Different Applications and Its Application Share 3.3 Cardinal Health, Inc. 3.3.1 Company Basic Information, Manufacturing Base and Competitors 3.3.2 Diabetic Gastroparesis Treatment Product Category, Application and Specification 3.3.2.1 Product A 3.3.2.2 Product B 3.3.3 Cardinal Health, Inc. Diabetic Gastroparesis Treatment Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.3.4 Cardinal Health, Inc. Different Types of Diabetic Gastroparesis Treatment Sales (K Units), Revenue (Million USD) and Price (USD/Unit) and (2012-2017) 3.3.5 Cardinal Health, Inc. Diabetic Gastroparesis Treatment Volume in Different Applications and Its Application Share 3.4 Salix Pharmaceuticals, Inc. 3.4.1 Company Basic Information, Manufacturing Base and Competitors 3.4.2 Diabetic Gastroparesis Treatment Product Category, Application and Specification 3.4.2.1 Product A 3.4.2.2 Product B 3.4.3 Salix Pharmaceuticals, Inc. Diabetic Gastroparesis Treatment Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.4.4 Salix Pharmaceuticals, Inc. Different Types of Diabetic Gastroparesis Treatment Sales (K Units), Revenue (Million USD) and Price (USD/Unit) and (2012-2017) 3.4.5 Salix Pharmaceuticals, Inc. Diabetic Gastroparesis Treatment Volume in Different Applications and Its Application Share 3.5 Alfa Wassermann SPA 3.5.1 Company Basic Information, Manufacturing Base and Competitors 3.5.2 Diabetic Gastroparesis Treatment Product Category, Application and Specification 3.5.2.1 Product A 3.5.2.2 Product B 3.5.3 Alfa Wassermann SPA Diabetic Gastroparesis Treatment Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.5.4 Alfa Wassermann SPA Different Types of Diabetic Gastroparesis Treatment Sales (K Units), Revenue (Million USD) and Price (USD/Unit) and (2012-2017) 3.5.5 Alfa Wassermann SPA Diabetic Gastroparesis Treatment Volume in Different Applications and Its Application Share 3.6 Abbott Laboratories 3.6.1 Company Basic Information, Manufacturing Base and Competitors 3.6.2 Diabetic Gastroparesis Treatment Product Category, Application and Specification 3.6.2.1 Product A 3.6.2.2 Product B 3.6.3 Abbott Laboratories Diabetic Gastroparesis Treatment Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.6.4 Abbott Laboratories Different Types of Diabetic Gastroparesis Treatment Sales (K Units), Revenue (Million USD) and Price (USD/Unit) and (2012-2017) 3.6.5 Abbott Laboratories Diabetic Gastroparesis Treatment Volume in Different Applications and Its Application Share 3.7 Medtronic Plc. 3.7.1 Company Basic Information, Manufacturing Base and Competitors 3.7.2 Diabetic Gastroparesis Treatment Product Category, Application and Specification 3.7.2.1 Product A 3.7.2.2 Product B 3.7.3 Medtronic Plc. Diabetic Gastroparesis Treatment Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.7.4 Medtronic Plc. Different Types of Diabetic Gastroparesis Treatment Sales (K Units), Revenue (Million USD) and Price (USD/Unit) and (2012-2017) 3.7.5 Medtronic Plc. Diabetic Gastroparesis Treatment Volume in Different Applications and Its Application Share 3.8 C. R. Bard, Inc. 3.8.1 Company Basic Information, Manufacturing Base and Competitors 3.8.2 Diabetic Gastroparesis Treatment Product Category, Application and Specification 3.8.2.1 Product A 3.8.2.2 Product B 3.8.3 C. R. Bard, Inc. Diabetic Gastroparesis Treatment Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.8.4 C. R. Bard, Inc. Different Types of Diabetic Gastroparesis Treatment Sales (K Units), Revenue (Million USD) and Price (USD/Unit) and (2012-2017) 3.8.5 C. R. Bard, Inc. Diabetic Gastroparesis Treatment Volume in Different Applications and Its Application Share 3.9 Rhythm Pharmaceuticals, Inc. 3.9.1 Company Basic Information, Manufacturing Base and Competitors 3.9.2 Diabetic Gastroparesis Treatment Product Category, Application and Specification 3.9.2.1 Product A 3.9.2.2 Product B 3.9.3 Rhythm Pharmaceuticals, Inc. Diabetic Gastroparesis Treatment Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.9.4 Rhythm Pharmaceuticals, Inc. Different Types of Diabetic Gastroparesis Treatment Sales (K Units), Revenue (Million USD) and Price (USD/Unit) and (2012-2017) 3.9.5 Rhythm Pharmaceuticals, Inc. Diabetic Gastroparesis Treatment Volume in Different Applications and Its Application Share 3.10 Boston Scientific Corporation 3.10.1 Company Basic Information, Manufacturing Base and Competitors 3.10.2 Diabetic Gastroparesis Treatment Product Category, Application and Specification 3.10.2.1 Product A 3.10.2.2 Product B 3.10.3 Boston Scientific Corporation Diabetic Gastroparesis Treatment Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.10.4 Boston Scientific Corporation Different Types of Diabetic Gastroparesis Treatment Sales (K Units), Revenue (Million USD) and Price (USD/Unit) and (2012-2017) 3.10.5 Boston Scientific Corporation Diabetic Gastroparesis Treatment Volume in Different Applications and Its Application Share 3.11 Kimberly-Clark Corporation 4 USA Diabetic Gastroparesis Treatment Competition by Players/Manufacturers, Region, Type and Application 4.1 USA Diabetic Gastroparesis Treatment Market Competition by Players/Manufacturers 4.1.1 USA Diabetic Gastroparesis Treatment Sales (K Units) and Market Share of Key Players/Suppliers (2012-2017) 4.1.2 USA Diabetic Gastroparesis Treatment Revenue (Million USD) and Share by Players/Suppliers (2012-2017) 4.2 USA Diabetic Gastroparesis Treatment Sales and Revenue by Type 4.2.1 USA Diabetic Gastroparesis Treatment Sales (K Units) and Market Share by Type (2012-2017) 4.2.2 USA Diabetic Gastroparesis Treatment Revenue (Million USD) and Market Share by Type (2012-2017) 4.3 USA Diabetic Gastroparesis Treatment Sales and Revenue by Application 4.3.1 USA Diabetic Gastroparesis Treatment Sales (K Units) and Market Share by Regions (2012-2017) 4.3.2 USA Diabetic Gastroparesis Treatment Revenue (Million USD) and Market Share (%) Regions (2012-2017) 4.4 USA Diabetic Gastroparesis Treatment Sales (K Units) by Application 5 Northeast Diabetic Gastroparesis Treatment (Sales, Revenue and Price) 5.1 Northeast Diabetic Gastroparesis Treatment Sales and Value (2012-2017) 5.1.1 Northeast Diabetic Gastroparesis Treatment Sales (K Units) and Growth Rate (2012-2017) 5.1.2 Northeast Diabetic Gastroparesis Treatment Revenue and Growth Rate (2012-2017) 5.1.3 Northeast Diabetic Gastroparesis Treatment Sales Price (USD/Unit) Trend (2012-2017) 5.2 Northeast Diabetic Gastroparesis Treatment Sales (K Units) and Market Share by Type 5.3 Northeast Diabetic Gastroparesis Treatment Sales (K Units) and Market Share by Application 6 Midwest Diabetic Gastroparesis Treatment (Sales, Revenue and Price) 6.1 Midwest Diabetic Gastroparesis Treatment Sales and Value (2012-2017) 6.1.1 Midwest Diabetic Gastroparesis Treatment Sales (K Units) and Growth Rate (2012-2017) 6.1.2 Midwest Diabetic Gastroparesis Treatment Revenue and Growth Rate (2012-2017) 6.1.3 Midwest Diabetic Gastroparesis Treatment Sales Price (USD/Unit) Trend (2012-2017) 6.2 Midwest Diabetic Gastroparesis Treatment Sales (K Units) and Market Share by Type 6.3 Midwest Diabetic Gastroparesis Treatment Sales (K Units) and Market Share by Application 7 South Diabetic Gastroparesis Treatment (Sales, Revenue and Price) 7.1 South Diabetic Gastroparesis Treatment Sales and Value (2012-2017) 7.1.1 South Diabetic Gastroparesis Treatment Sales (K Units) and Growth Rate (2012-2017) 7.1.2 South Diabetic Gastroparesis Treatment Revenue and Growth Rate (2012-2017) 7.1.3 South Diabetic Gastroparesis Treatment Sales Price (USD/Unit) Trend (2012-2017) 7.2 South Diabetic Gastroparesis Treatment Sales (K Units) and Market Share by Type 7.3 South Diabetic Gastroparesis Treatment Sales (K Units) and Market Share by Application 8 West Diabetic Gastroparesis Treatment (Sales, Revenue and Price) 8.1 West Diabetic Gastroparesis Treatment Sales and Value (2012-2017) 8.1.1 West Diabetic Gastroparesis Treatment Sales (K Units) and Growth Rate (2012-2017) 8.1.2 West Diabetic Gastroparesis Treatment Revenue and Growth Rate (2012-2017) 8.1.3 West Diabetic Gastroparesis Treatment Sales Price (USD/Unit) Trend (2012-2017) 8.2 West Diabetic Gastroparesis Treatment Sales (K Units) and Market Share by Type 8.3 West Diabetic Gastroparesis Treatment Sales (K Units) and Market Share by Application 11 Marketing Strategy Analysis, Distributors/Traders 11.1 Direct Marketing 11.1.1 Direct Marketing 11.1.2 Indirect Marketing 11.1.3 Marketing Channel Development Trend 11.2 Market Positioning 11.2.1 Pricing Strategy 11.2.2 Brand Strategy 11.2.3 Target Client 11.3 Distributors/Traders List 12 USA Diabetic Gastroparesis Treatment Market Forecast (2018-2023) 12.1 USA Diabetic Gastroparesis Treatment Sales (K Units), Revenue and Price Forecast (2018-2023) 12.1.1 USA Diabetic Gastroparesis Treatment Sales (K Units) and Growth Rate Forecast (2018-2023) 12.1.2 USA Diabetic Gastroparesis Treatment Revenue and Growth Rate Forecast (2018-2023) 12.1.3 USA Diabetic Gastroparesis Treatment Price and Trend Forecast (2018-2023) 12.2 USA Diabetic Gastroparesis Treatment Sales (K Units), Revenue and Growth Rate Forecast by Region (2018-2023) 12.2.1 USA Diabetic Gastroparesis Treatment Sales (K Units) and Growth Rate Forecast by Region (2018-2023) 12.2.2 USA Diabetic Gastroparesis Treatment Revenue and Growth Rate Forecast by Region (2018-2023) 12.2.3 Northeast Diabetic Gastroparesis Treatment Sales, Revenue and Growth Rate Forecast (2018-2023) 12.2.4 Midwest Diabetic Gastroparesis Treatment Sales, Revenue and Growth Rate Forecast (2018-2023) 12.2.5 Midwest Diabetic Gastroparesis Treatment Sales, Revenue and Growth Rate Forecast (2018-2023) 12.2.6 West Diabetic Gastroparesis Treatment Sales, Revenue and Growth Rate Forecast (2018-2023) 12.3 USA Diabetic Gastroparesis Treatment Sales, Revenue and Price Forecast by Type (2018-2023) 12.3.1 USA Diabetic Gastroparesis Treatment Sales Forecast by Type (2018-2023) 12.3.2 USA Diabetic Gastroparesis Treatment Revenue Forecast by Type (2018-2023) 12.3.3 USA Diabetic Gastroparesis Treatment Price Forecast by Type (2018-2023) 12.4 USA Diabetic Gastroparesis Treatment Sales Forecast by Application (2018-2023) 13 Research Findings and Conclusion 14 Appendix 14.1 Methodology/Research Approach 14.1.1 Research Programs/Design 14.1.2 Market Size Estimation 14.1.3 Market Breakdown and Data Triangulation 14.2 Data Source 14.2.1 Secondary Sources 14.2.2 Primary Sources 14.3 Disclaimer

List of Tables and Figures Figure USA Market Size (Million USD) Comparison 2012-2023 Table USA Market Diabetic Gastroparesis Treatment Revenue (Million USD) Comparison by Regions 2012-2023 Table USA Diabetic Gastroparesis Treatment Sales (K Units) and Revenue (Million USD) Market Split by Product Type Table USA Diabetic Gastroparesis Treatment Sales (K Units) by Application (2016-2023) Figure Product Picture of Diabetic Gastroparesis Treatment Table USA Diabetic Gastroparesis Treatment Sales (K Units) and Growth Rate (%) Comparison by Types (2012-2023) Figure USA Diabetic Gastroparesis Treatment Sales (K Units) Market Share by Types in 2017 Figure Gastroprokinetic Agents Picture Figure Antiemetic Agents Picture Figure Botulinum Toxin Picture Table USA Diabetic Gastroparesis Treatment Sales (K Units) Comparison by Applications (2012-2023) Figure USA Sales Market Share of Diabetic Gastroparesis Treatment by Applications in 2017 Figure Compensated Gastroparesis Examples Figure Gastric Failure Examples Figure Others Examples Table USA Market Diabetic Gastroparesis Treatment Revenue (Million USD) Comparison by Regions 2012-2023 Figure Northeast Diabetic Gastroparesis Treatment Revenue (Million USD) and Growth Rate (2012-2023) Figure Midwest Diabetic Gastroparesis Treatment Revenue (Million USD) and Growth Rate (2012-2023) Figure South Diabetic Gastroparesis Treatment Revenue (Million USD) and Growth Rate (2012-2023) Figure West Diabetic Gastroparesis Treatment Revenue (Million USD) and Growth Rate (2012-2023) Figure USA Diabetic Gastroparesis Treatment Sales (K Units) and Growth Rate (2012-2023) Figure USA Diabetic Gastroparesis Treatment Revenue (Million USD) and Growth Rate (2012-2023) Figure New Project SWOT Analysis of Diabetic Gastroparesis Treatment Table Industry News List of Diabetic Gastroparesis Treatment Figure Industry Chain Structure of Diabetic Gastroparesis Treatment Table Raw Material Suppliers and Price Analysis Figure Global Raw Material A Price Trend (USD/MT) Figure Global Raw Material B Price Trend (USD/MT) Figure Global Raw Material C Price Trend (USD/MT) Table Manufacturing Cost Structure Analysis of Diabetic Gastroparesis Treatment in 2017 Figure Manufacturing Process Analysis of Diabetic Gastroparesis Treatment Table Raw Materials Sources of Diabetic Gastroparesis Treatment Major Manufacturers in 2017 Table Major Buyers of Diabetic Gastroparesis Treatment Table Janssen Global Services, LLC Basic Information List Table Janssen Global Services, LLC Diabetic Gastroparesis Treatment Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure Janssen Global Services, LLC Diabetic Gastroparesis Treatment Sales Growth Rate (2012-2017) Figure Janssen Global Services, LLC Diabetic Gastroparesis Treatment Sales USA Market Share (%) (2012-2017) Figure Janssen Global Services, LLC Diabetic Gastroparesis Treatment Revenue USA Market Share (%) (2012-2017) Table Gastroprokinetic Agents Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Antiemetic Agents Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Botulinum Toxin Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Janssen Global Services, LLC Diabetic Gastroparesis Treatment Volume in and Its Application Share Table Janssen Global Services, LLC Diabetic Gastroparesis Treatment Volume in and Its Application Share Table Janssen Global Services, LLC Diabetic Gastroparesis Treatment Volume in and Its Application Share Table Evoke Pharma Basic Information List Table Evoke Pharma Diabetic Gastroparesis Treatment Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure Evoke Pharma Diabetic Gastroparesis Treatment Sales Growth Rate (2012-2017) Figure Evoke Pharma Diabetic Gastroparesis Treatment Sales USA Market Share (%) (2012-2017) Figure Evoke Pharma Diabetic Gastroparesis Treatment Revenue USA Market Share (%) (2012-2017) Table Gastroprokinetic Agents Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Antiemetic Agents Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Botulinum Toxin Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Evoke Pharma Diabetic Gastroparesis Treatment Volume in and Its Application Share Table Evoke Pharma Diabetic Gastroparesis Treatment Volume in and Its Application Share Table Evoke Pharma Diabetic Gastroparesis Treatment Volume in and Its Application Share Table Cardinal Health, Inc. Basic Information List Table Cardinal Health, Inc. Diabetic Gastroparesis Treatment Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure Cardinal Health, Inc. Diabetic Gastroparesis Treatment Sales Growth Rate (2012-2017) Figure Cardinal Health, Inc. Diabetic Gastroparesis Treatment Sales USA Market Share (%) (2012-2017) Figure Cardinal Health, Inc. Diabetic Gastroparesis Treatment Revenue USA Market Share (%) (2012-2017) Table Gastroprokinetic Agents Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Antiemetic Agents Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Botulinum Toxin Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Cardinal Health, Inc. Diabetic Gastroparesis Treatment Volume in and Its Application Share Table Cardinal Health, Inc. Diabetic Gastroparesis Treatment Volume in and Its Application Share Table Cardinal Health, Inc. Diabetic Gastroparesis Treatment Volume in and Its Application Share Table Salix Pharmaceuticals, Inc. Basic Information List Table Salix Pharmaceuticals, Inc. Diabetic Gastroparesis Treatment Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure Salix Pharmaceuticals, Inc. Diabetic Gastroparesis Treatment Sales Growth Rate (2012-2017) Figure Salix Pharmaceuticals, Inc. Diabetic Gastroparesis Treatment Sales USA Market Share (%) (2012-2017) Figure Salix Pharmaceuticals, Inc. Diabetic Gastroparesis Treatment Revenue USA Market Share (%) (2012-2017) Table Gastroprokinetic Agents Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Antiemetic Agents Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Botulinum Toxin Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Salix Pharmaceuticals, Inc. Diabetic Gastroparesis Treatment Volume in and Its Application Share Table Salix Pharmaceuticals, Inc. Diabetic Gastroparesis Treatment Volume in and Its Application Share Table Salix Pharmaceuticals, Inc. Diabetic Gastroparesis Treatment Volume in and Its Application Share Table Alfa Wassermann SPA Basic Information List Table Alfa Wassermann SPA Diabetic Gastroparesis Treatment Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure Alfa Wassermann SPA Diabetic Gastroparesis Treatment Sales Growth Rate (2012-2017) Figure Alfa Wassermann SPA Diabetic Gastroparesis Treatment Sales USA Market Share (%) (2012-2017) Figure Alfa Wassermann SPA Diabetic Gastroparesis Treatment Revenue USA Market Share (%) (2012-2017) Table Gastroprokinetic Agents Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Antiemetic Agents Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Botulinum Toxin Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Alfa Wassermann SPA Diabetic Gastroparesis Treatment Volume in and Its Application Share Table Alfa Wassermann SPA Diabetic Gastroparesis Treatment Volume in and Its Application Share Table Alfa Wassermann SPA Diabetic Gastroparesis Treatment Volume in and Its Application Share Table Abbott Laboratories Basic Information List Table Abbott Laboratories Diabetic Gastroparesis Treatment Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure Abbott Laboratories Diabetic Gastroparesis Treatment Sales Growth Rate (2012-2017) Figure Abbott Laboratories Diabetic Gastroparesis Treatment Sales USA Market Share (%) (2012-2017) Figure Abbott Laboratories Diabetic Gastroparesis Treatment Revenue USA Market Share (%) (2012-2017) Table Gastroprokinetic Agents Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Antiemetic Agents Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Botulinum Toxin Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Abbott Laboratories Diabetic Gastroparesis Treatment Volume in and Its Application Share Table Abbott Laboratories Diabetic Gastroparesis Treatment Volume in and Its Application Share Table Abbott Laboratories Diabetic Gastroparesis Treatment Volume in and Its Application Share Table Medtronic Plc. Basic Information List Table Medtronic Plc. Diabetic Gastroparesis Treatment Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure Medtronic Plc. Diabetic Gastroparesis Treatment Sales Growth Rate (2012-2017) Figure Medtronic Plc. Diabetic Gastroparesis Treatment Sales USA Market Share (%) (2012-2017) Figure Medtronic Plc. Diabetic Gastroparesis Treatment Revenue USA Market Share (%) (2012-2017) Table Gastroprokinetic Agents Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Antiemetic Agents Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Botulinum Toxin Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Medtronic Plc. Diabetic Gastroparesis Treatment Volume in and Its Application Share Table Medtronic Plc. Diabetic Gastroparesis Treatment Volume in and Its Application Share Table Medtronic Plc. Diabetic Gastroparesis Treatment Volume in and Its Application Share Table C. R. Bard, Inc. Basic Information List Table C. R. Bard, Inc. Diabetic Gastroparesis Treatment Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure C. R. Bard, Inc. Diabetic Gastroparesis Treatment Sales Growth Rate (2012-2017) Figure C. R. Bard, Inc. Diabetic Gastroparesis Treatment Sales USA Market Share (%) (2012-2017) Figure C. R. Bard, Inc. Diabetic Gastroparesis Treatment Revenue USA Market Share (%) (2012-2017) Table Gastroprokinetic Agents Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Antiemetic Agents Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Botulinum Toxin Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table C. R. Bard, Inc. Diabetic Gastroparesis Treatment Volume in and Its Application Share Table C. R. Bard, Inc. Diabetic Gastroparesis Treatment Volume in and Its Application Share Table C. R. Bard, Inc. Diabetic Gastroparesis Treatment Volume in and Its Application Share Table Rhythm Pharmaceuticals, Inc. Basic Information List Table Rhythm Pharmaceuticals, Inc. Diabetic Gastroparesis Treatment Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure Rhythm Pharmaceuticals, Inc. Diabetic Gastroparesis Treatment Sales Growth Rate (2012-2017) Figure Rhythm Pharmaceuticals, Inc. Diabetic Gastroparesis Treatment Sales USA Market Share (%) (2012-2017) Figure Rhythm Pharmaceuticals, Inc. Diabetic Gastroparesis Treatment Revenue USA Market Share (%) (2012-2017) Table Gastroprokinetic Agents Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Antiemetic Agents Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Botulinum Toxin Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Rhythm Pharmaceuticals, Inc. Diabetic Gastroparesis Treatment Volume in and Its Application Share Table Rhythm Pharmaceuticals, Inc. Diabetic Gastroparesis Treatment Volume in and Its Application Share Table Rhythm Pharmaceuticals, Inc. Diabetic Gastroparesis Treatment Volume in and Its Application Share Table Company Boston Scientific Corporation Basic Information List Table Company Boston Scientific Corporation Diabetic Gastroparesis Treatment Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure Company Boston Scientific Corporation Diabetic Gastroparesis Treatment Sales Growth Rate (2012-2017) Figure Company Boston Scientific Corporation Diabetic Gastroparesis Treatment Sales USA Market Share (%) (2012-2017) Figure Company Boston Scientific Corporation Diabetic Gastroparesis Treatment Revenue USA Market Share (%) (2012-2017) Table Gastroprokinetic Agents Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Antiemetic Agents Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Botulinum Toxin Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Company Boston Scientific Corporation Diabetic Gastroparesis Treatment Volume in and Its Application Share Table Company Boston Scientific Corporation Diabetic Gastroparesis Treatment Volume in and Its Application Share Table Company Boston Scientific Corporation Diabetic Gastroparesis Treatment Volume in and Its Application Share Table USA Diabetic Gastroparesis Treatment Sales (K Units) by Players/Manufacturers (2012-2017) Table USA Diabetic Gastroparesis Treatment Sales Share (%) by Players/Manufacturers (2012-2017) Figure 2016 USA Diabetic Gastroparesis Treatment Sales Market Share (%) by Players/Manufacturers Figure 2017 USA Diabetic Gastroparesis Treatment Sales Share by Players/Manufacturers Table USA Diabetic Gastroparesis Treatment Revenue (Million USD) by Players/Manufacturers (2012-2017) Table USA Diabetic Gastroparesis Treatment Revenue Market Share (%) Players/Manufacturers (2012-2017) Figure 2016 USA Diabetic Gastroparesis Treatment Revenue Market Share (%) Players Figure 2017 USA Diabetic Gastroparesis Treatment Revenue Market Share (%) Players Table USA Diabetic Gastroparesis Treatment Sales (K Units) and Market Share (%) by Type (2012-2017) Table USA Diabetic Gastroparesis Treatment Sales Share by Type (2012-2017) Figure Sales Market Share of Diabetic Gastroparesis Treatment by Type (2012-2017) Figure USA Diabetic Gastroparesis Treatment Sales Growth Rate (%) by Type (2012-2017) Table USA Diabetic Gastroparesis Treatment Revenue (Million USD) and Market Share (%) Type (2012-2017) Table USA Diabetic Gastroparesis Treatment Revenue Market Share (%) Type (2012-2017) Figure Revenue Market Share of Diabetic Gastroparesis Treatment by Type (2012-2017) Figure USA Diabetic Gastroparesis Treatment Revenue Growth Rate by Type (2012-2017) Table USA Diabetic Gastroparesis Treatment Sales (K Units) and Market Share by Regions (2012-2017) Table USA Diabetic Gastroparesis Treatment Sales Share by Regions (2012-2017) Figure Sales Market Share of Diabetic Gastroparesis Treatment by Regions (2012-2017) Figure USA Diabetic Gastroparesis Treatment Sales Market Share by Regions in 2017 Table USA Diabetic Gastroparesis Treatment Revenue (Million USD) and Market Share by Regions (2012-2017) Table USA Diabetic Gastroparesis Treatment Revenue Share (%) by Regions (2012-2017) Figure Revenue Market Share of Diabetic Gastroparesis Treatment by Regions (2012-2017) Figure USA Diabetic Gastroparesis Treatment Revenue Market Share by Regions in 2017 Table USA Diabetic Gastroparesis Treatment Sales (K Units) and Market Share by Application (2012-2017) Table USA Diabetic Gastroparesis Treatment Sales Share (%) by Application (2012-2017) Figure USA Diabetic Gastroparesis Treatment Sales Market Share by Application (2012-2017) Figure USA Diabetic Gastroparesis Treatment Sales Market Share by Application (2012-2017) Figure Northeast Diabetic Gastroparesis Treatment Sales (K Units) and Growth Rate (%) (2012-2017) Figure Northeast Diabetic Gastroparesis Treatment Revenue (Million USD) and Growth Rate (%) (2012-2017) Figure Northeast Diabetic Gastroparesis Treatment Sales Price (USD/Unit) Trend (2012-2017) Table Northeast Diabetic Gastroparesis Treatment Sales (K Units) by Type (2012-2017) Table Northeast Diabetic Gastroparesis Treatment Sales (K Units) Market Share by Type (2012-2017) Figure Northeast Diabetic Gastroparesis Treatment Sales (K Units) Market Share by Type in 2017 Table Northeast Diabetic Gastroparesis Treatment Sales (K Units) by Applications (2012-2017) Table Northeast Diabetic Gastroparesis Treatment Sales (K Units) Market Share by Applications (2012-2017) Figure Northeast Diabetic Gastroparesis Treatment Sales (K Units) Market Share by Applications in 2017 Figure Midwest Diabetic Gastroparesis Treatment Sales (K Units) and Growth Rate (2012-2017) Figure Midwest Diabetic Gastroparesis Treatment Revenue (Million USD) and Growth Rate (%) (2012-2017) Figure Midwest Diabetic Gastroparesis Treatment Sales Price (USD/Unit) Trend (2012-2017) Table Midwest Diabetic Gastroparesis Treatment Sales (K Units) by Type (2012-2017) Table Midwest Diabetic Gastroparesis Treatment Sales (K Units) Market Share by Type (2012-2017) Figure Midwest Diabetic Gastroparesis Treatment Sales (K Units) Market Share by Type in 2017 Table Midwest Diabetic Gastroparesis Treatment Sales (K Units) by Applications (2012-2017) Table Midwest Diabetic Gastroparesis Treatment Sales (K Units) Market Share by Applications (2012-2017) Figure Midwest Diabetic Gastroparesis Treatment Sales (K Units) Market Share by Applications in 2017 Figure South Diabetic Gastroparesis Treatment Sales (K Units) and Growth Rate (2012-2017) Figure South Diabetic Gastroparesis Treatment Revenue (Million USD) and Growth Rate (%) (2012-2017) Figure South Diabetic Gastroparesis Treatment Sales Price (USD/Unit) Trend (2012-2017) Table South Diabetic Gastroparesis Treatment Sales (K Units) by Type (2012-2017) Table South Diabetic Gastroparesis Treatment Sales (K Units) Market Share by Type (2012-2017) Figure South Diabetic Gastroparesis Treatment Sales (K Units) Market Share by Type in 2017 Table South Diabetic Gastroparesis Treatment Sales (K Units) by Applications (2012-2017) Table South Diabetic Gastroparesis Treatment Sales (K Units) Market Share by Applications (2012-2017) Figure South Diabetic Gastroparesis Treatment Sales (K Units) Market Share by Applications in 2017 Figure West Diabetic Gastroparesis Treatment Sales (K Units) and Growth Rate (2012-2017) Figure West Diabetic Gastroparesis Treatment Revenue (Million USD) and Growth Rate (%) (2012-2017) Figure West Diabetic Gastroparesis Treatment Sales Price (USD/Unit) Trend (2012-2017) Table West Diabetic Gastroparesis Treatment Sales (K Units) by Type (2012-2017) Table West Diabetic Gastroparesis Treatment Sales (K Units) Market Share by Type (2012-2017) Figure West Diabetic Gastroparesis Treatment Sales (K Units) Market Share by Type in 2017 Table West Diabetic Gastroparesis Treatment Sales (K Units) by Applications (2012-2017) Table West Diabetic Gastroparesis Treatment Sales (K Units) Market Share by Applications (2012-2017) Figure West Diabetic Gastroparesis Treatment Sales (K Units) Market Share by Applications in 2017 Table Distributors/Traders List Figure USA Diabetic Gastroparesis Treatment Sales (K Units) and Growth Rate Forecast (2018-2023) Figure USA Diabetic Gastroparesis Treatment Revenue (Million USD) and Growth Rate (%) Forecast (2018-2023) Figure USA Diabetic Gastroparesis Treatment Price and Trend Forecast (2018-2023) Table USA Diabetic Gastroparesis Treatment Sales (K Units) Forecast by Regions (2018-2023) Figure USA Diabetic Gastroparesis Treatment Sales (K Units) Market Share Forecast by Regions (2018-2023) Figure USA Diabetic Gastroparesis Treatment Sales (K Units) Market Share Forecast by Regions in 2023 Table USA Diabetic Gastroparesis Treatment Revenue (Million USD) Forecast by Regions (2018-2023) Figure USA Diabetic Gastroparesis Treatment Revenue Market Share Forecast by Regions (2018-2023) Figure USA Diabetic Gastroparesis Treatment Revenue Market Share Forecast by Regions in 2023 Figure Northeast Diabetic Gastroparesis Treatment Sales (K Units) and Growth Rate (%) Forecast (2018-2023) Figure Northeast Diabetic Gastroparesis Treatment Revenue (Million USD) and Growth Rate (%) Forecast (2018-2023) Figure South Diabetic Gastroparesis Treatment Sales (K Units) and Growth Rate (%) Forecast (2018-2023) Figure South Diabetic Gastroparesis Treatment Revenue (Million USD) and Growth Rate (%) Forecast (2018-2023) Figure Midwest Diabetic Gastroparesis Treatment Sales (K Units) and Growth Rate (%) Forecast (2018-2023) Figure Midwest Diabetic Gastroparesis Treatment Revenue (Million USD) and Growth Rate (%) Forecast (2018-2023) Figure West Diabetic Gastroparesis Treatment Sales (K Units) and Growth Rate (%) Forecast (2018-2023) Figure West Diabetic Gastroparesis Treatment Revenue (Million USD) and Growth Rate (%) Forecast (2018-2023) Table USA Diabetic Gastroparesis Treatment Sales (K Units) Forecast by Type (2018-2023) Figure USA Diabetic Gastroparesis Treatment Sales Market Share Forecast by Type (2018-2023) Table USA Diabetic Gastroparesis Treatment Revenue (Million USD) Forecast by Type (2018-2023) Figure USA Diabetic Gastroparesis Treatment Revenue Market Share Forecast by Type (2018-2023) Table USA Diabetic Gastroparesis Treatment Price (USD/Unit) Forecast by Type (2018-2023) Table USA Diabetic Gastroparesis Treatment Sales (K Units) Forecast by Application (2018-2023) Figure USA Diabetic Gastroparesis Treatment Sales Market Share Forecast by Application (2018-2023) Table Research Programs/Design for This Report Figure Bottom-up and Top-down Approaches for This Report Figure Data Triangulation Table Key Data Information from Secondary Sources Table Key Data Information from Primary Sources

Janssen Global Services, LLC Evoke Pharma Cardinal Health, Inc. Salix Pharmaceuticals, Inc. Alfa Wassermann SPA Abbott Laboratories Medtronic Plc. C. R. Bard, Inc. Rhythm Pharmaceuticals, Inc. Boston Scientific Corporation Kimberly-Clark Corporation